Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.3K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SpaceHASTEN: A Structure-Based Virtual Screening Tool for Nonenumerated Virtual Chemical Libraries.

Journal of chemical information and modeling·2024
See all related articles

Related Experiment Video

Updated: Nov 3, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

702

Machine Learning Boosted Docking (HASTEN): An Open-source Tool To Accelerate Structure-based Virtual Screening

Tuomo Kalliokoski1

  • 1Orion Pharma, Orionintie 1 A, 02101, Espoo, Finland.

Molecular Informatics
|June 1, 2021
PubMed
Summary

The HASTEN software uses machine learning to speed up drug discovery screening. It effectively identifies promising molecules, achieving high recall rates in virtual screening tests.

Keywords:
dockingmachine learningstructure-based virtual screening

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.2K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

537

Related Experiment Videos

Last Updated: Nov 3, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

702
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.2K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

537

Area of Science:

  • Computational chemistry
  • cheminformatics
  • machine learning

Background:

  • Structure-based virtual screening is crucial for drug discovery.
  • Accelerating virtual screening can significantly reduce the time and cost of identifying potential drug candidates.
  • Machine learning models offer a promising approach to enhance screening efficiency.

Purpose of the Study:

  • To develop and validate a machine learning-boosted docking software named HASTEN.
  • To accelerate structure-based virtual screening processes.
  • To assess the performance of HASTEN using diverse datasets.

Main Methods:

  • HASTEN software was developed integrating machine learning models with docking protocols.
  • Validation was performed using 12 literature datasets (3 million molecules docked with FRED) and one in-house dataset (4 million compounds docked with Glide).
  • Performance was evaluated based on recall values for top-scoring molecules after partial dataset docking.

Main Results:

  • HASTEN demonstrated reasonable performance on literature data with a mean recall of 0.78 for the top 1% of molecules after docking 10% of the dataset.
  • Excellent recall of 0.95 was achieved for the in-house dataset.
  • The software is compatible with various docking and machine learning methodologies.

Conclusions:

  • HASTEN effectively accelerates structure-based virtual screening using machine learning.
  • The software shows high performance in identifying active compounds, particularly with in-house data.
  • HASTEN is a valuable, freely available tool for computational drug discovery.